Riparian Pharmaceuticals Inc

Sherlock Biosciences, a subsidiary of OraSure Technologies, is pioneering the democratization and decentralization of molecular diagnostics by leveraging the power of CRISPR and synthetic biology. The company is dedicated to creating rapid, accurate, and affordable diagnostic tools for DNA and RNA detection, enabling personalized healthcare at the point-of-need. With a team of experts in Engineering Biology, Sherlock Biosciences is committed to transforming current healthcare paradigms. Their innovative platforms SHERLOCK and INSPECTR provide straightforward solutions for disease detection, ensuring that critical health information is accessible to everyone, anywhere. Generated from the website

Lyra Therapeutics is a clinical-stage biotechnology company based in Watertown, MA, focused on developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS). With a commitment to addressing the needs of the 14 million individuals in the United States suffering from this debilitating condition, Lyra aims to provide long-lasting treatment options that break the cycle of relentless medical management. The company's lead product candidate, LYR210, features a bioabsorbable nasal mesh designed to deliver continuous anti-inflammatory medication directly to the sinonasal tissues for up to six months. By integrating advanced materials science with proven medication, Lyra Therapeutics is poised to transform the treatment landscape for CRS patients, offering a new solution for an often overlooked community. Generated from the website

Addgene Inc, based in Watertown, MA, serves as a nonprofit repository facilitating the sharing of valuable research materials and information within the scientific community. With a mission spanning over two decades, Addgene simplifies access to research tools by storing, distributing, and managing plasmids, viral vectors, and recombinant antibodies. Scientists worldwide have requested materials from Addgene over 2 million times, underscoring its global impact. By offering a diverse collection of 153,770 plasmids, 975 viral vectors, and 229 antibodies, Addgene empowers researchers to advance their experiments and discoveries. Noteworthy is the expanded viral service that allows users to select from a pool of over 3,000 AAV plasmids for custom viral preparation, supported by Addgene's stringent quality control measures and expert teams. This service enhances the flexibility and efficiency of viral vector research. Generated from the website content